Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 9, member C pseudogene (often symbolized as FAM9CP or FAM9C pseudogene) is a processed pseudogene in the human genome. It is classified as a pseudogene because it has lost its protein-coding ability or is otherwise nonfunctional due to mutations or lack of regulatory elements. Pseudogenes like this are considered remnants of once-functional genes and usually do not produce a functional protein. Occasionally, certain pseudogenes have been implicated in gene regulation (for example, acting as competing endogenous RNAs or influencing parent gene expression), but there is no evidence that "Family with sequence similarity 9, member C pseudogene" is therapeutically relevant, nor does it serve as a direct drug target or biomarker[1][3][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 9, member C pseudogene (FAM9CP).